Neuronal IL-1R1 Signaling in Mild Closed Head Injury
Neuronal IL-1R1 Signaling in Mild Closed Head Injury
批准号:
10656547
负责人:
ADAM D BACHSTETTER
金额:
$42.91万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2027-05-31
关键词:
AcuteAddressAgeAnimal Disease ModelsAnti-Inflammatory AgentsAttentionAutoimmune DiseasesAxonBehaviorBehavioral AssayBrainCellsChronicClosed head injuriesComplexDataDevelopmentElectrophysiology (science)ExhibitsFDA approvedFormulationFunctional disorderGene Expression ProfileGenesGoalsInflammationInflammatoryInflammatory ResponseInjuryInterleukin SuppressionInterleukin-1Interleukin-1 ReceptorsInterventionKnockout MiceKnowledgeLoxP-flanked alleleMaintenanceMediatingMemoryModelingMusNatureNerve DegenerationNervous System TraumaNeurodegenerative DisordersNeurogliaNeuronsPathway interactionsPeripheralPhasePhenotypePhysiologyProcessReceptor SignalingRecoveryRiboTagRoleSignal TransductionSynapsesSynaptic plasticitySystemTestingTherapeuticTissuesTraumatic Brain Injurycell typecognitive functioncognitive recoverycytokineexperimental studygenetic approachinducible Creinflammatory milieuinterleukin-1 receptor accessory proteinknock-downmouse modelnerve injurynervous system disorderneuroinflammationneuroprotectionneuroregulationnovelpreservationresponsesynaptic function
中文摘要
摘要
众所周知,细胞因子白介素1(IL-1)在外周组织中介导有害的炎症过程
纸巾。IL-1在年龄和神经退行性疾病中升高。因此,IL-1成为人们关注的主要焦点
抗炎策略治疗急性和慢性损伤后的神经炎症
神经退行性疾病。令人惊讶的是,几乎没有证据表明神经元通过直接的
IL-1的作用。相反,神经元特异性的非规范的IL-1受体(IL-1R1)途径
促进而不是侵蚀神经元的活性已经被确定。尽管有这种范式转换的观察,
非正则途径几乎没有受到关注。关于神经元IL-1R1如何
信号有助于大脑的炎症环境、突触生理和认知功能,以及
从损伤中恢复和神经退变的进展。这种知识鸿沟可能会削弱潜力。
以抑制IL-1为目标的神经保护方法是作用机制的一部分。
为了解决这一知识鸿沟,我们将使用显示神经元特异性调节IL-1的新型小鼠模型
信号(即,IL-1R1诱导的小鼠查看神经元特异性基因敲除,而IL-1R1恢复的小鼠查看
神经元特异性表达IL-1R1)。我们的主要假设是神经元IL-1R1信号是
与生俱来的保护性。
我们将在以下具体目标中检验这一假设:
SA1定义了神经元IL-1R1通路在小鼠对CHI的炎症反应中的作用。
SA2在小鼠CHI后的稳态突触可塑性中定义了神经元IL-1R1通路。
SA3决定了神经元IL-1R1在脑缺血后认知恢复中的时间作用。
如果我们的假设得到证实,我们将提供一种新的神经保护方法的知识,并使
开发现有抗炎干预措施的新配方,以保护神经保护
IL-1的功能。新的IL-1R1疗法的开发将包括仅抑制
炎症性IL-1R1途径或仅激活神经保护性IL-1R1途径。
英文摘要
ABSTRACT
The cytokine interleukin-1 (IL-1) is well known to mediate detrimental inflammatory processes in peripheral
tissues. IL-1 is elevated in age and in neurodegenerative disease. As a result, IL-1 has become a major focus
of anti-inflammatory strategies to treat neuroinflammation following acute injury and in chronic
neurodegenerative disease. Surprisingly, there is scant evidence that neurons are damaged through the direct
actions of IL-1. To the contrary, a neuron-specific “non-canonical” IL-1 receptor (IL-1R1) pathway that
promotes, rather than erodes, neuronal viability has been identified. Despite this paradigm-shifting observation,
the non-canonical pathway has received little attention. Much remains unknown about how neuronal IL-1R1
signaling contributes to the brain's inflammatory milieu, synaptic physiology, and cognitive function, and
recover from injury and progression of neurodegeneration. This knowledge gap could undermine potential
neuroprotective approaches that target suppression of IL-1 as part of the mechanism-of-action.
To address this knowledge gap, we will use novel mouse models exhibiting neuron-specific modulation of IL-1
signaling (i.e., IL-1R1-floxed mice to look at neuron-specific knockdown and IL-1R1-restore mice to look at the
neuron-specific expression of IL-1R1). Our overarching hypothesis is that neuronal IL-1R1 signaling is
inherently protective.
We will test this hypothesis in the following Specific Aims:
SA1 Define the role of the neuronal IL-1R1 pathway in the inflammatory response to a CHI in mice.
SA2 Define the neuronal IL-1R1 pathway in homeostatic synaptic plasticity after a CHI in mice.
SA3 Determine the temporal role of neuronal IL-1R1 in the cognitive recovery following a CHI.
If our hypothesis is affirmed, we will provide knowledge of a new neuroprotective approach and enable the
development of new formulations of existing anti-inflammatory interventions that preserve the neuroprotective
functions of IL-1. The development of novel IL-1R1 therapies would include agents that only suppress the
inflammatory IL-1R1 pathway or only activate the neuroprotective IL-1R1 pathway.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Drug repurposing for Alzheimer’s disease-related inflammation caused by a TBI
-
批准号:10590132
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2023
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Neuronal IL-1R1 Signaling in Mild Closed Head Injury
-
批准号:10518172
-
项目类别:
-
资助金额:$44.24万
-
财政年份:2022
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Translational Approaches to Mitigate Enhanced Alzheimer’s Disease Risk Following a Mild TBI
-
批准号:10090757
-
项目类别:
-
资助金额:$114.75万
-
财政年份:2021
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Administrative Supplement to Sleep Fragmentation and Alzheimer's Disease
-
批准号:10555721
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2020
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Sleep Fragmentation and Alzheimer’s Disease
-
批准号:10029813
-
项目类别:
-
资助金额:$73.69万
-
财政年份:2020
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Sleep Fragmentation and Alzheimer’s Disease
-
批准号:10398182
-
项目类别:
-
资助金额:$74.16万
-
财政年份:2020
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Sleep Fragmentation and Alzheimer’s Disease
-
批准号:10219957
-
项目类别:
-
资助金额:$75.23万
-
财政年份:2020
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Sleep Fragmentation and Alzheimer’s Disease
-
批准号:10611958
-
项目类别:
-
资助金额:$72.93万
-
财政年份:2020
-
负责人:ADAM D BACHSTETTER
-
依托单位:
SLC9A1 and Neurodegenerative Disease
-
批准号:9898214
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2019
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Cell-Specific Actions of IL-1 / IL-1R1 Signaling Following Traumatic Brain Injury
-
批准号:10307112
-
项目类别:
-
资助金额:$32.72万
-
财政年份:2018
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Cell-Specific Actions of IL-1 / IL-1R1 Signaling Following Traumatic Brain Injury
-
批准号:10540718
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2018
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Involvement of myelin integrity in Alzheimer's disease pathogenesis
-
批准号:9267404
-
项目类别:
-
资助金额:$24.44万
-
财政年份:2016
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Involvement of myelin integrity in Alzheimer's disease pathogenesis
-
批准号:8634180
-
项目类别:
-
资助金额:$8.94万
-
财政年份:2013
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Involvement of myelin integrity in Alzheimer's disease pathogenesis
-
批准号:8776907
-
项目类别:
-
资助金额:$8.57万
-
财政年份:2013
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Harnessing microglia towards repair vs. damage: Does p38 MAPK hold the reins?
-
批准号:8080960
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2010
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Harnessing microglia towards repair vs. damage: Does p38 MAPK hold the reins?
-
批准号:7911520
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Harnessing microglia towards repair vs. damage: Does p38 MAPK hold the reins?
-
批准号:8231475
-
项目类别:
-
资助金额:$2.71万
-
财政年份:2010
-
负责人:ADAM D BACHSTETTER
-
依托单位:
海外基金